Correction of excessive anticoagulation with low-dose oral vitamin K1

Ann Intern Med. 1997 Jun 15;126(12):959-62. doi: 10.7326/0003-4819-126-12-199706150-00005.

Abstract

Background: Despite earlier acceptance of oral vitamin K1 (phytonadione) for the treatment of excessive anticoagulation, some recent guidelines do not recommend its use.

Objective: To reevaluate the efficacy of oral vitamin K1 in correcting excessive anticoagulation.

Design: Case series.

Setting: Anticoagulation clinics at two university medical centers.

Patients: 81 outpatients who had an international normalized ratio (INR) greater than 5.0 but did not have significant bleeding.

Interventions: Withholding 1 or 2 doses of warfarin, administering 2.5 mg of oral vitamin K1, measuring the INR after 24 to 48 hours, and adjusting the warfarin dose.

Measurements: INRs were obtained from a portable capillary fingerstick monitor or from an automated photooptical coagulometer.

Results: In 68 of 71 patients (96%), oral vitamin K1 lowered the INR from between 5.0 and 10.0 to less than 5.0 without inducing resistance to further anticoagulation.

Conclusions: Withholding 1 or 2 doses of warfarin and administering 2.5 mg of oral vitamin K1 is a reliable, safe, and inexpensive way to rapidly correct excessive anticoagulation (INR > 5.0) in patients who do not have serious bleeding episodes and have an INR of less than 10.0.

Publication types

  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Hemorrhage / chemically induced
  • Hemorrhage / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Vitamin K / administration & dosage*

Substances

  • Anticoagulants
  • Vitamin K